NIH Licenses Revolutionary CAR Tech to Fight Autoimmune Diseases
Published Date: 7/3/2025
Notice
Summary
The National Cancer Institute plans to give Capstan Therapeutics an exclusive license to use a new invention that helps treat or prevent B cell autoimmune diseases using a special CAR therapy. This means Capstan can develop and sell this treatment, potentially speeding up new options for patients. The deal could bring exciting medical advances and business growth starting soon.
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in